REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr. Abidi Pharmaceuticals Company Public Joint Stock (Iran)

Main Activities: Medicinal and Botanical Manufacturing | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Dr. Abidi Pharmaceuticals Company Public Joint Stock Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Dr.Abidi Pharmaceutical Laboratory is an Iranian company, established in 1973 in Tehran. It is a pharmaceutical researcher, developer, manufacturer and wholesaler. It provides various dosage forms, such as syrups, gels, capsules, tablets and ointments. Pills are manufactured in a 1,000 sq.m. in Tehran. The company also engages in import and export operations. It has one foreign branch in Samarkand, Uzbekistan, established in 2002. The company’s predecessor Dr.Abidi Laboratory started operations in 1946 producing one type of anti-parasites tablet.

Headquarters
8Th Km Of Shahid Lashgari Expressway, (Karaj Makhsoos Road), Abidi Boulevard - No. 72, Po Box 13445-156
Tehran; Tehran; Postal Code: 13897-76363

Contact Details: Purchase the Dr. Abidi Pharmaceuticals Company Public Joint Stock report to view the information.

Website: http://www.abidipharma.com

Basic Information
Total Employees:
Purchase the Dr. Abidi Pharmaceuticals Company Public Joint Stock report to view the information.
Outstanding Shares:
Purchase the Dr. Abidi Pharmaceuticals Company Public Joint Stock report to view the information.
Financial Auditors:
Purchase the Dr. Abidi Pharmaceuticals Company Public Joint Stock report to view the information.
Incorporation Date:
1973
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Vice Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
66%
Purchase this report to view the information.
19%
Purchase this report to view the information.
4%
Purchase this report to view the information.
2%
Subsidiaries
Hema Pars Daru Company
Ofogh Tadbir Salamat Company
Company Performance
Financial values in the chart are available after Dr. Abidi Pharmaceuticals Company Public Joint Stock report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
56.16%
Total operating revenue
55.92%
Operating profit (EBIT)
53.82%
EBITDA
54.81%
Net Profit (Loss) for the Period
44.47%
Total assets
81.1%
Total equity
64.76%
Operating Profit Margin (ROS)
-0.71%
Net Profit Margin
-2.51%
Return on Equity (ROE)
-6.22%
Debt to Equity Ratio
27.2%
Quick Ratio
-0.29%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?